Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cumberland Pharmaceuticals, Inc.    CPIX

CUMBERLAND PHARMACEUTICALS, INC.

(CPIX)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

CUMBERLAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 05:18pm EDT

Item 2.02 Results of Operations and Financial Condition.


On August 14, 2019, Cumberland Pharmaceuticals Inc. (the "Company") issued a
press release which highlighted the 14% revenue growth in the second quarter and
the operating results for the three and six months ended June 30, 2019. A copy
of the press release is attached as   Exhibit 99.1   to this Current Report on
Form 8-K and is incorporated by reference into this Item 2.02.
This information is furnished pursuant to Item 2.02 of Form 8-K and shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), or otherwise subject to the liabilities of that
section, unless specifically incorporated by reference in a document filed under
the Securities Act of 1933, as amended, or the Exchange Act. By filing this
report on Form 8-K and furnishing this information, the Company makes no
admission as to the materiality of any information in this report that is
required to be disclosed solely by Item 2.02.
Item 9.01  Financial Statements and Exhibits
(d) Exhibits

Exhibit No.   Description

  99.1          Press release dated August 14, 2019




--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CUMBERLAND PHARMACEUTICALS
08/14CUMBERLAND PHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
AQ
08/14CUMBERLAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (..
AQ
08/14CUMBERLAND : 2Q Earnings Snapshot
AQ
08/14CUMBERLAND PHARMACEUTICALS : Reports 14% Revenue Growth In The Second Quarter
PR
08/07CUMBERLAND PHARMACEUTICALS : To Announce Second Quarter 2019 Financial Results
PR
07/18CUMBERLAND PHARMACEUTICALS : Message from CEO
PU
06/11CUMBERLAND PHARMACEUTICALS : Emerging Technologies Welcomes Launch Tennessee's M..
AQ
05/16CUMBERLAND PHARMACEUTICALS : Message from CEO
PU
05/16CUMBERLAND PHARMACEUTICALS : Clinigen to assume control of us commercial rights ..
AQ
05/15CUMBERLAND PHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
AQ
More news